News
Two appointed to Tetra Pharm Technologies management board
Published
7 months agoon
By
News Editor

Danish biotech company Tetra Pharm Technologies has announced the appointment of Steen Jakobsen as Chief Financial Officer (CFO) and Jacob Schlundt as Chief Marketing Officer (CMO).
The company develops and manufactures pharmaceutical drugs targeting the endocannabinoid system for the treatment of neuropathic pain, sclerosis and mental health disorders.
Tetra Pharm Technologies CEO, Martin Rose, said:
“Tetra Pharm Technologies has reached a size that makes it necessary to expand the management board.
“We are very ambitious about our future growth potential, and the expansion of the management team with experienced profiles such as Steen and Jacob, is an obvious and timely strengthening of the company.”
Jakobsen holds an MSc in Business Administration and Commercial Law from Copenhagen Business School.
He joins Tetra Pharm Technologies from Dubai’s Department of Economy and Tourism, where he held the position of Vice President.
Jakobsen has extensive experience in strategic planning, finance, and management, and he will take responsibility of the overall finance function at Tetra Pharm Technologies.
Steen Jakobsen said:
“Tetra Pharm Technologies is a very compelling company with strong values and a promising future that I am excited to be a part of.
“I look forward to contributing to the continued positive development and to accelerating our highly ambitious growth strategy in collaboration with my new colleagues.’
Shlundt holds a degree in International Business Information from Copenhagen Business College.
He joins Tetra Pharm Technologies from his role as Head of Marketing & Communications at Aon Denmark, bringing extensive experience in marketing, communications and event planning.
Jacob Schlundt said:
“I am very motivated by Tetra Pharm Technologies’ mission of developing effective and affordable drugs, and I’m excited about contributing to making a genuine difference for patients and their families.
“I’m also looking forward to developing myself personally and professionally in a team of far-sighted, competent, and dedicated.”
60
SHARES
You may like


Microsoft invests £2.5 billion in UK AI


TMS shows promise in tackling depression ‘epidemic’


AI depression app set for NHS clinical trial


UK Biobank releases world’s largest single set of sequencing data


Listen: Longevity, Eastern wisdom and Western science


Fundamental principles of healthcare digital twins


Tackling the diagnostic testing sustainability problem


Gym-going men ‘unaware’ of protein risk to fertility


Anti-choke mug protects Parkinson’s patients


AI model predicts breast cancer risk without racial bias
Sign up for free updates from Health Tech World
Trending stories
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion7 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- AI3 weeks ago
AI can help predict survival outcomes for cancer patients
- Research4 days ago
Tackling the diagnostic testing sustainability problem